Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANBESURE study of extended bemiparin prophylaxis after oncologic abdominal or pelvic surgery
2005-004373-23Phase 3Completed
- Sponsor
- Laboratorios Farmacéuticos ROVI
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venous thromboembolism (VTE) comparing Extended bemiparin prophylaxis with Short-course bemiparin followed by placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jun 2007; status: completed.
02
Drugs
bemiparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on 2005-004373-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004373-23.